Summary
Industry
Insights
Gleamer, based in Paris, has significant potential by providing AI software to improve the accuracy and efficiency of radiologists in interpreting medical images. Focusing on health tech, Gleamer addresses challenges in radiology such as diagnostic errors, slow processing times, and high workloads. Their B2B model targets healthcare institutions directly, ensuring steady demand. Supported by prominent investors, Gleamer's AI technology could revolutionize medical imaging, reduce human error, and lead to better patient outcomes. This specific focus on radiology allows Gleamer to carve out a niche market, positioning itself as an essential tool for modern healthcare facilities.
Investors
Elaia Series B
Supernova Invest Series B
Supernova Invest Series B
Bpifrance Series B
Heal Capital Series B
XAnge Series A
Full Company Profile
- Access details of the company management, and other intelligence on this company by registering for Seedtable